4. Nitrosative Stress in the ER: A New Role for S-Nitrosylation in Neurodegenerative Diseases. ACS Chem Biol 1: 355-8. (2006).

5. Basal and stimulated protein S-nitrosylation in multiple cell types and tissues. J Biol Chem 277: 9637-40. (2002).

6. S-nitrosylation is emerging as a specific and fundamental posttranslational protein modification: head-to-head comparison with O-phosphorylation.
     Sci STKE 2001: RE1. (2001).

7. Shear stress increases the amount of S-nitrosylated molecules in endothelial cells: important role for signal transduction.
     FEBS Lett 551: 153-8. (2003).

8. Further evidence that rat liver microsomal glutathione transferase 1 is not a cellular protein target for S-nitrosylation.
     Chem Biol Interact 162(3):228-36. (2006).

9. S-Nitrosylation: NO-Related Redox Signaling to Protect Against Oxidative Stress. Antioxid Redox Signal 8 (9-10): 1693-705. (2006).

10. Say NO to Neurodegeneration: Role of S-Nitrosylation in Neurodegenerative Disorders. Neurosignals 15: 307-313. (2007).

11. Protein S-nitrosylation: A role of nitric oxide signaling in cardiac ischemic preconditioning. Sheng Li Xue Bao 59: 544-52. (2007).

12. Studying the S-nitrosylation of model peptides and eNOS protein by mass spectrometry. Nitric Oxide 13: 176-87. (2005).

13. S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J Biol Chem 280: 7511-8. (2005).

14. Fas-induced caspase denitrosylation. Science 284: 651-4. (1999).

15. S-nitrosylation of microtubule-associated protein 1B mediates nitric-oxide-induced axon retraction. Nat Cell Biol. 9(9):1035-45. (2007).

16. S-Nitrosylation of mitochondrial caspases. J Cell Biol 154: 1111-6. (2001).

17. Identification of the Cysteine Nitrosylation Sites in Human Endothelial Nitric Oxide Synthase. DNA Cell Biol. 2007 Oct 17;
       [Epub ahead of print]

18. Human spermatozoa contain multiple targets for protein S-nitrosylation: An alternative mechanism of the modulation of sperm function
       by nitric oxide? Proteomics. Sep;7(17):3066-84. (2007).

19. S-nitrosylation of IRP2 regulates its stability via the ubiquitin-proteasome pathway. Mol Cell Biol 24: 330-7. (2004).

20. S-nitrosylation: a potential new paradigm in signal transduction. Cardiovasc Res 62: 43-52. (2004).

21. New insights into protein S-nitrosylation. Mitochondria as a model system. J Biol Chem 279: 25891-7. (2004).

22. S-nitrosylation of proteins. Cell Mol Life Sci 55: 1036-42. (1999).

23. Proteomic identification of S-nitrosylated proteins in Arabidopsis. Plant Physiol 137: 921-30. (2005).

24. A Novel Approach to Identify Proteins Modified by Nitric Oxide: the HIS-TAG Switch Method. J Proteome Res. 6(8):3224-31. (2007).

25. S-Nitrosylation: an emerging redox-based post-translational modification in plants. J Exp Bot 57(8):1777-84 (2006).

26. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297: 1186-90. (2002).

27. An autocatalytic mechanism of protein nitrosylation. Proc Natl Acad Sci U S A 97: 13543-8. (2000).

28. Assessment of S-nitrosothiols on diaminofluorescein gels. Anal Biochem 346: 69-76. (2005).

29. In situ detection and visualization of S-nitrosylated proteins following chemical derivatization: identification of Ran GTPase as a target
       for S-nitrosylation. Nitric Oxide 11: 216-27. (2004).

30. Regulation and specificity of S-nitrosylation and denitrosylation. ACS Chem Biol 1: 615-8. (2006).

31. S-nitrosothiol depletion in amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 103: 2404-9. (2006).

32. High glucose attenuates protein S-nitrosylation in endothelial cells: role of oxidative stress. Diabetes. 56(11):2715-21. (2007).

33. Nitric oxide inhibits c-Jun N-terminal kinase 2 (JNK2) via S-nitrosylation. Biochem Biophys Res Commun 247: 809-13. (1998).

34. Inducible NO Synthase Dependent S-Nitrosylation and Activation of Arginase1 Contribute to Age-Related
       Endothelial Dysfunction. Circ Res 101(7):692-702. (2007).

35. S-nitroso proteome of Mycobacterium tuberculosis: Enzymes of intermediary metabolism and antioxidant defense.
       Proc Natl Acad Sci U S A 102: 467-72. (2005).

36. Identification of S-nitrosylated proteins in endotoxin-stimulated RAW264.7 murine macrophages. Nitric Oxide 12: 121-6. (2005).

37. S-nitrosylation/Denitrosylation and Apoptosis of Immune Cells. Cell Mol Immunol 4: 353-358. (2007).

38. S-nitrosylation in Parkinson's disease and related neurodegenerative disorders. Methods Enzymol 396: 139-50. (2005).

39. Regulation of apoptosis by nitrosative stress. J Biochem Mol Biol 35: 127-33. (2002).

40. Nitric oxide protects against mitochondrial permeabilization induced by glutathione depletion: role of S-nitrosylation?
       Biochem Biophys Res Commun 339: 255-62. (2006).

41. Immunoregulatory and antimicrobial effects of nitrogen oxides. Proc Am Thorac Soc 3: 161-5. (2006).

42. Accumulation of misfolded protein through nitrosative stress linked to neurodegenerative disorders.
       Antioxid Redox Signal 9: 597-601. (2007).

43. Mechanism of extracellular thiol nitrosylation by N(2)O(3) produced by activated macrophages. Nitric Oxide 3: 467-72. (1999).

44. Mechanism of p21Ras S-nitrosylation and kinetics of nitric oxide-mediated guanine nucleotide exchange. Biochemistry 43: 2314-22. (2004).

45. Differential effects of nitric oxide-mediated S-nitrosylation on p50 and c-jun DNA binding. Surgery 124: 137-41;
       discussion 141-2. (1998).

46. Subcellular targeting and differential S-nitrosylation of endothelial nitric-oxide synthase. J Biol Chem 281: 151-7. (2006).

47. Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem
       280: 19888-94. (2005).

48. Posttranslational modification of glyceraldehyde-3-phosphate dehydrogenase by S-nitrosylation and subsequent NADH attachment.
       J Biol Chem 271: 4209-14. (1996).

49. Preconditioning Results in S-Nitrosylation of Proteins Involved in Regulation of Mitochondrial Energetics and Calcium Transport.
       Circ Res 101(11):1155-63. (2007).

50. Non-heme iron protein: a potential target of nitric oxide in acute cardiac allograft rejection. Proc Natl Acad Sci U S A 100: 3125-30. (2003).

51. Regulation of beta-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2. Cell 129: 511-22. (2007).

52. Nitrite catalyzes ferriheme protein reductive nitrosylation. J Am Chem Soc 125: 10510-1. (2003).

53. Gel electrofocusing method for studying protein S-nitrosylation. Methods Enzymol 301: 145-51. (1999).

54. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol 3: 193-7. (2001).

55. Regulation of S-thiolation and S-nitrosylation in the thiol/nitric oxide system by radical scavengers. Nitric Oxide 16(3):356-61. (2007).

56. S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding.
       Cell Death Differ 14(7):1305-14. (2007).

57. S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities.
       Proc Natl Acad Sci U S A 102: 8525-30. (2005).

58. Nitrosopeptide mapping: a novel methodology reveals s-nitrosylation of dexras1 on a single cysteine residue.
       Chem Biol 9: 1329-35. (2002).

59. Differential inhibition of Arabidopsis methionine adenosyltransferases by protein S-nitrosylation. J Biol Chem 281: 4285-91. (2006).

60. Nitric oxide regulates endocytosis by S-nitrosylation of dynamin. Proc Natl Acad Sci U S A 103: 1295-300. (2006).sssss

61. In vivo regulation by glutathione of methionine adenosyltransferase S-nitrosylation in rat liver. J Hepatol 31: 887-94. (1999).

62. NOS2 regulation of NF-kappa B by S-nitrosylation of p65* J Biol Chem 282(42):30667-72. (2007).

63. S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteasomal degradation: A novel anti-apoptotic mechanism that suppresses apoptosis.
      J Biol Chem 281(45):34124-34. (2006).

64. Detection and identification of S-nitrosylated proteins in endothelial cells. Methods Enzymol 396: 131-9. (2005).

65. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 304: 1328-31. (2004).

66. Nitrosative Stress and Pathogenesis of Insulin Resistance. Antioxid Redox Signal 9(3):319-29. (2007).

67. Crystal structure of the S-nitroso form of liganded human hemoglobin. Biochemistry 37: 16459-64. (1998).

68. Suppression of neuronal apoptosis by S-nitrosylation of caspases. Neurosci Lett 236: 139-42. (1997).

69. Balancing reactivity against selectivity: The evolution of protein S-nitrosylation as an effector of cell signaling by nitric oxide.
       Cardiovasc Res 75(2):210-9. (2007).

70. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective
       function of statins. Circulation 110: 856-61. (2004).

71. Nitric oxide activates TRP channels by cysteine S-nitrosylation. Nat Chem Biol 2(11):570-1. (2006).

72. Activation of cytosolic phospholipase A2alpha through nitric oxide-induced S-nitrosylation: Involvement of inducible nitric
       oxide synthase and cyclooxygenase-2. J Biol Chem. [Epub ahead of print]. (2007).

73. Nitric oxide inhibits myocardial apoptosis by preventing caspase-3 activity via S-nitrosylation. J Mol Cell Cardiol 38: 163-74. (2005).

74. Proteomic analysis of S-nitrosylated proteins in mesangial cells. Mol Cell Proteomics 2: 156-63. (2003).

75. Assessment and application of the biotin switch technique for examining protein S-nitrosylation under conditions of pharmacologically
       induced oxidative stress. J Biol Chem 282(19):13977-83. (2007).

76. Structural and biochemical studies of p21Ras S-nitrosylation and nitric oxide-mediated guanine nucleotide exchange.
       Proc Natl Acad Sci U S A 100: 6376-81. (2003).

77. Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase.
       J Biol Chem 274: 9427-30. (1999).

78. Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes.
      Proc Natl Acad Sci USA. 104(51):20612-7. (2007).

79. Metacaspase activity of Arabidopsis thaliana is regulated by S-nitrosylation of a critical cysteine residue. J Biol Chem (2007).

80. Nitric oxide can inhibit apoptosis or switch it into necrosis. Cell Mol Life Sci 57: 612-22. (2000).

81. A novel scavenger of nitric oxide decreases heme protein nitrosylation and prolongs graft survivial during cardiac transplant rejection.
      J Heart Lung Transplant 20: 157. (2001).

82. Identification of S-nitrosylation motifs by site-specific mapping of the S-nitrosocysteine proteome in human vascular smooth muscle cells.
      Proc Natl Acad Sci U S A 103(19):7420-5. (2006).

83. Methionine adenosyltransferase S-nitrosylation is regulated by the basic and acidic amino acids surrounding the target thiol.
       J Biol Chem 274: 17075-9. (1999).

84. Regulation of MyD88-dependent signaling events by S-nitrosylation retards Toll-like receptor signal transduction and initiation of
       acute-phase immune responses. Mol Cell Biol. [Epub ahead of print]. (2007).

85. Nitric oxide, NOC-12, and S-nitrosoglutathione modulate the skeletal muscle calcium release channel/ryanodine receptor by
       different mechanisms. An allosteric function for O2 in S-nitrosylation of the channel. J Biol Chem 278: 8184-9. (2003).

86. Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of cysteine 360 in the active site of the enzyme.
       J Biol Chem 276: 34458-64. (2001).

87. Nitric oxide, S-nitrosylation and neurodegeneration. Cell Mol Biol (Noisy-le-grand) 51: 247-54. (2005).

88. Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat Neurosci 3: 15-21. (2000).

89. Alteration of NF-kappa B p50 DNA binding kinetics by S-nitrosylation. Biochem Biophys Res Commun 238: 703-6. (1997).

90. Cys25-nitrosylation inactivates papain. Biochem Mol Biol Int 46: 425-8. (1998).

91. Cysteine regulation of protein function--as exemplified by NMDA-receptor modulation. Trends Neurosci 25: 474-80. (2002).

92. Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases
       endogenous ADP-ribosylation. J Biol Chem        267: 24929-32. (1992).

93. Direct nitric oxide signal transduction via nitrosylation of iron-sulfur centers in the SoxR transcription activator.
       Proc Natl Acad Sci U S A 97: 5146-50. (2000).

94. Detection and characterization of protein nitrosothiols. Methods Enzymol 396: 105-18. (2005).

95. Inhibition of protein-tyrosine phosphatases by mild oxidative stresses is dependent on S-nitrosylation. J Biol Chem 280: 14453-61. (2005).

96. Inhibition of AtMYB2 DNA-binding by nitric oxide involves cysteine S-nitrosylation. Biochem Biophys Res Commun 361(4):1048-53. (2007).

97. Nitric oxide: a signal for ADP-ribosylation of proteins. Life Sci 54: 61-70. (1994).

98. Nitric oxide transfer from the NO-donor S-nitroso-N-acetylpenicillamine to monomers and dimers of water-soluble iron-porphyrins.
       J Inorg Biochem 98: 459-68. (2004).

99. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441: 513-7. (2006).

100. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat Cell Biol 4: 743-9. (2002).

101. S-nitrosylation in health and disease. Trends Mol Med 9: 160-8. (2003).

102. NMDA Receptor-Nitric Oxide Transmission Mediates Neuronal Iron Homeostasis via the GTPase Dexras1. Neuron 51: 431-40. (2006).

103. Inhibition of NF-kappa B by S-nitrosylation. Biochemistry 40: 1688-93. (2001).

104. Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells.
         Cardiovasc Res 75(2):349-58.. (2007).

105. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol 7: 665-74. (2005).

106. S-Nitrosylation of Platelet alpha(IIb)beta(3) As Revealed by Raman Spectroscopy. Biochemistry [Epub ahead of print]. (2007).

107. S-nitrosylation of NSF controls membrane trafficking. Cell 115: 127-9. (2003).

108. Electrochemical and spectral studies on the reductive nitrosylation of water-soluble iron porphyrin. Inorg Chem 42: 1945-51. (2003).

109. A novel mechanism underlying the susceptibility of neuronal cells to nitric oxide: the occurrence and regulation of protein
         S-nitrosylation is the checkpoint. J Neurochem 102: 1863-74. (2007).

110. Effect of nitric oxide on the ligand-binding activity of albumin. Arch Biochem Biophys 345: 237-42. (1997).

111. Nitric oxide inactivates rat hepatic methionine adenosyltransferase In vivo by S-nitrosylation. Hepatology 28: 1051-7. (1998).

112. Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism. Cardiovasc Res 72(1):80-9 (2006).

113. S-nitrosylation and permeation through connexin 43 hemichannels in astrocytes: Induction by oxidant stress and reversal by reducing agents.
        Proc Natl Acad Sci U S A 103(12):4475-80. (2006).

114. Neuronal nitric oxide synthase induced S-nitrosylation of H-Ras inhibits calcium ionophore-mediated extracellular signal-regulated kinase activity.
        Biochem J 397(2):329-36. (2006).

115. S-nitrosylation and S-glutathiolation of protein sulfhydryls by S-nitroso glutathione. Arch Biochem Biophys 362: 67-78. (1999).

116. Signalling by NO-induced protein S-nitrosylation and S-glutathionylation: Convergences and divergences. Cardiovasc Res 75(2):220-8. (2007).

117. Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: regulation of estrogen-dependent gene transcription.
          Proc Natl Acad Sci U S A 102: 2632-6. (2005).

118. Argininosuccinate synthetase is reversibly inactivated by S-nitrosylation in vitro and in vivo. J Biol Chem 279: 36192-200. (2004).

119. Unbiased identification of cysteine S-nitrosylation sites on proteins. Nat Protoc 2: 1685-91. (2007).

120. Ca2+ pool emptying stimulates Ca2+ entry activated by S-nitrosylation. J Biol Chem 273: 30855-8. (1998).

121. Detection and proteomic identification of S-nitrosylated proteins in endothelial cells. Arch Biochem Biophys 423: 192-9. (2004).

122. S-nitrosylation of viral proteins: molecular bases for antiviral effect of nitric oxide. IUBMB Life 48: 25-31. (1999).

123. S-nitrosylation of cysteine 289 of the AT(1) receptor decreases its binding affinity for angiotensin II. Br J Pharmacol 148(3):306-13. (2006).

124. Nitric oxide inhibits ADP-ribosyl cyclase through a cGMP-independent pathway in airway smooth muscle.
          Am J Physiol Lung Cell Mol Physiol 283: L1065-71. (2002).

125. Cysteine nitrosylation inactivates the HIV-1 protease. Biochem Biophys Res Commun 250: 575-6. (1998).

126. TNFalpha and oxLDL reduce protein S-nitrosylation in endothelial cells. J Biol Chem 276: 41383-7. (2001).

127. S-nitrosylation of N-ethylmaleimide sensitive factor mediates surface expression of AMPA receptors. Neuron 46: 533-40. (2005).

128. Enhancement of S-nitrosylation in glycosylated hemoglobin. Biochem Biophys Res Commun 271: 217-21. (2000).

129. S-nitrosoglutathione inhibits alpha1-adrenergic receptor-mediated vasoconstriction and ligand binding in pulmonary artery.
        Am J Physiol Lung Cell Mol Physiol 290: L136-43. (2006).

130. Emerging Roles of S-Nitrosylation in Protein Misfolding and Neurodegenerative Diseases. Antioxid Redox Signal 10(1):87-102 (2008).

131. Endotoxin-mediated S-nitrosylation of p50 alters NF-kappa B-dependent gene transcription in ANA-1 murine macrophages.
          J Immunol 162: 4101-8. (1999).

132. S-nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity.
          Proc Natl Acad Sci U S A 101: 2619-24. (2004).

133. Regulation of platelet granule exocytosis by S-nitrosylation. Proc Natl Acad Sci U S A 102: 3782-7. (2005).

134. Effect of nitric oxide in amyloid fibril formation on transthyretin-related amyloidosis. Biochemistry 44: 11122-9. (2005).

135. Nitric oxide-mediated inhibition of Hdm2-p53 binding. Biochemistry 41: 13570-4. (2002).

136. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279: 234-7. (1998).

137. Screening for nitric oxide-dependent protein-protein interactions. Science 301: 657-61. (2003).

138. Selective nitrosyl group transfer reaction to cytidine using oligonucleotides bearing S-nitrosothioguanosine.
          Nucleic Acids Symp Ser (Oxf) 0: 23-24. (2004).

139. Mass spectrometry-based analyses for identifying and characterizing S-nitrosylation of protein tyrosine phosphatases.
          Methods 42: 243-249. (2007).

140. Oxidative stress and S-nitrosylation of proteins in cells. Br J Pharmacol 129: 953-60. (2000).

141. Human glutathione transferase P1-1 and nitric oxide carriers; a new role for an old enzyme. J Biol Chem 276: 42138-45. (2001).

142. Proteomic identification of s-nitrosylated proteins in endothelial cells. Methods Mol Biol 357: 215-24. (2006).

143. Activation of RAS upregulates pro-apoptotic BNIP3 in nitric oxide-induced cell death. J Biol Chem 281(45):33939-48. (2006).

144. S-nitrosylation: spectrum and specificity. Nat Cell Biol 3: E46-9. (2001).

145. S-nitrosylation regulates apoptosis. Nature 388: 432-3. (1997).

146. Direct inhibition by nitric oxide of the transcriptional ferric uptake regulation protein via nitrosylation of the iron.
          Proc Natl Acad Sci U S A 99: 16619-24. (2002).

147. Inhibition of nitrosylation, nitration, lymphocyte proliferation, and gene expression in acute and delayed cardiac allograft rejection
          by an orally active dithiocarbamate. J Cardiovasc Pharmacol 43: 522-30. (2004).

148. Nitrosylation of thiols in vascular homeostasis and disease. Curr Atheroscler Rep 7: 213-8. (2005).

149. Ca(2+) entry activated by S-nitrosylation. Relationship to store-operated ca(2+) entry. J Biol Chem 274: 35318-24. (1999).

150. Redox modulation of the NMDA receptor by NO-related species. Prog Brain Res 118: 73-82. (1998).

151. S-nitrosylation TRiPs a calcium switch. Nat Chem Biol 2: 570-1. (2006).

152. A central role for S-nitrosylation in apoptosis. Nat Cell Biol 7: 645-6. (2005).

153. Inhibition of suicidal erythrocyte death by nitric oxide. Pflugers Arch [Epub ahead of print]. (2007).

154. Biological significance of nitric oxide-mediated protein modifications. Am J Physiol Lung Cell Mol Physiol 287: L262-8. (2004).

155. Down-regulation of nuclear receptor DNA-binding activity by nitric oxide--HNF4 as a model system. Med Sci Monit 8: RA217-20. (2002).

156. Prion, amyloid beta-derived Cu(II) ions, or free Zn(II) ions support S-nitroso-dependent autocleavage of glypican-1 heparan sulfate.
          J Biol Chem 278: 38956-65. (2003).

157. Increased protein nitrosylation in head and neck squamous cell carcinogenesis. Head Neck 22: 64-70. (2000).

158. Nitric oxide modulation of voltage-gated calcium current by S-nitrosylation and cGMP pathway in cultured rat hippocampal neurons.
          Biochem Biophys Res Commun 359(3):481-5. (2007).

159. cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO. Trends Neurosci 25: 510-7. (2002).

160. Nitrosylation. the prototypic redox-based signaling mechanism. Cell 106: 675-83. (2001).

161. Fas ligand-induced apoptosis is regulated by nitric oxide through the inhibition of fas receptor clustering and the nitrosylation of
          protein kinase Cepsilon. Exp Cell Res 313(16):3421-31. (2007).

162. Inhibition of mitochondrial aldehyde dehydrogenase by nitric oxide-mediated S-nitrosylation. FEBS Lett 579: 6115-20. (2005).

163. Nitric oxide negatively regulates Fas CD95-induced apoptosis through inhibition of ubiquitin-proteasome-mediated degradation of
          FLICE inhibitory protein. J Biol Chem 280: 42044-50. (2005).

164. Signal transduction by nitric oxide in cellular stress responses. Mol Cell Biochem 234: 11-8. (0).

165. Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme and nonheme iron proteins in vascular smooth muscle cells.
          Exp Cell Res 214: 418-28. (1994).

166. Detection of cysteine S-nitrosylation and tyrosine 3-nitration in kidney proteins. Methods Mol Med 86: 373-84. (2003).

167. Nitric oxide block of outward-rectifying K+ channels indicates direct control by protein nitrosylation in guard cells.
          Plant Physiol 136: 4275-84. (2004).

168. Detection of human IgG antibodies against free N-acetyl-L-cysteine. Immunol Lett 48: 49-52. (1995).

169. Polynitrosylated proteins: characterization, bioactivity, and functional consequences. Proc Natl Acad Sci U S A 93: 4736-41. (1996).

170. Nitrite Impurities Are Responsible for the Reaction Observed between Vitamin B(12) and Nitric Oxide in Acidic Aqueous Solution.
          Inorg Chem 45: 7869-7876. (2006).

171. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78: 31-6. (1994).

172. Regulation of transglutaminases by nitric oxide. Ann N Y Acad Sci 887: 83-91. (1999).

173. Nitric Oxide-Dependent Suppression of Thioredoxin-Interacting Protein Expression Enhances Thioredoxin Activity.
          Arterioscler Thromb Vasc Biol 26(12):2666-72. (2006).

174. Mechanisms of reductive nitrosylation in iron and copper models relevant to biological systems. Chem Rev 105: 2439-55. (2005).

175. Comment on "S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function".
          Science 308: 1870; author reply 1870. (2005).

176. Inhibition of the catalytic activity of rhodanese by S-nitrosylation using nitric oxide donors. Int J Biochem Cell Biol
          35: 1645-57. (2003).

177. Neuronal protection and destruction by NO. Cell Death Differ 6: 943-51. (1999).

178. Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry 40: 4904-10. (2001).

179. Involvement of GAPDH in tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated death of
          thyroid cancer cells. Endocrinology 148(9):4352-61. (2007).

180. Biological significance of nitration, nitrosation and nitrosylation in vivo. Nippon Yakurigaku Zasshi 112: 161-8. (1998).

181. Reductive nitrosylation and proton-assisted bridge splitting of a (mu-oxo)dimanganese(III) complex derived from a
          polypyridine ligand with one carboxamide group. Inorg Chem 44: 8469-75. (2005).

182. Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell 116: 617-28. (2004).

183. Decomposition of protein nitrosothiolsin matrix-assisted laser desorption/ionization and electrospray ionization
          mass spectrometry. J Mass Spectrom 38: 526-30. (2003).

184. Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. Proc Natl Acad Sci U S A 101: 8945-50. (2004).

185. Nitric oxide promotes endothelial cell survival signaling through S-nitrosylation and activation of dynamin-2.
          J Cell Sci 120: 492-501. (2007).

186. Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo.
          Proc Natl Acad Sci U S A 101: 4308-13. (2004).

187. Cardiac capsaicin-sensitive sensory nerves regulate myocardial relaxation via S-nitrosylation of SERCA: role of peroxynitrite.
          Br J Pharmacol [Epub ahead of print]. (2007).

188. S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide
          synthase and dimethylarginine dimethylaminohydrolase. Proc Natl Acad Sci U S A 99: 13527-32. (2002).

189. Nipradilol inhibits apoptosis by preventing the activation of caspase-3 via S-nitrosylation and the cGMP-dependent pathway.
          Eur J Pharmacol 452: 263-8. (2002).

190. Regulation of beta cell glucokinase by S-nitrosylation and association with nitric oxide synthase. J Cell Biol 161: 243-8. (2003).

191. Concentration-dependent Effects of Nitric Oxide on Angiogenesis of Lung Microvascular Endothelial Cells: Role of Calpain Nitrosylation.
        Proc Am Thorac Soc 3: 548a-549. (2006).

192. Intramolecular reductive nitrosylation: reaction of nitric oxide and a copper(II) complex of a cyclam derivative with pendant
          luminescent chromophores. J Am Chem Soc 126: 6564-5. (2004).

193. Nitric oxide in the central nervous system. Prog Brain Res 103: 359-64. (1994).

194. Nitrosative stress: activation of the transcription factor OxyR. Cell 86: 719-29. (1996).

195. Nitric oxide S-nitrosylates serine racemase, mediating feedback inhibition of D-serine formation.
          Proc Natl Acad Sci U S A 104(8):2950-5. (2007).

196. Heme and the endothelium. Effects of nitric oxide on catalytic iron and heme degradation by heme oxygenase.
          J Biol Chem 273: 23388-97. (1998).

197. Inhibition of glutamate uptake and proton pumping in synaptic vesicles by S-nitrosylation.
          J Neurochem 66: 1943-8. (1996).

198. Reductive nitrosylation and S-nitrosation of hemoglobin in inhomogeneous nitric oxide solutions.
          Nitric Oxide 10: 74-82. (2004).

199. N-nitrosylation potential of mono-N-desethylamiodarone at physiological pH. J Pharm Biomed Anal 34: 399-407. (2004).

200. Valsartan reverses post-translational modifications of the delta-subunit of ATP synthase during in vivo canine
          reperfused myocardial infarction. Proteomics 7(12):2100-10. (2007).

201. Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis.
          Am J Physiol Gastrointest Liver Physiol 281: G626-34. (2001).

202. The redox pathway of S-nitrosoglutathione, glutathione and nitric oxide in cell to neuron communications.
          Free Radic Res 31: 641-50. (1999).

203. Sodium nitroprusside promotes IRP2 degradation via an increase in intracellular iron and in the absence of S nitrosylation at C178.
          Mol Cell Biol 26: 1948-54. (2006).

204. Reductive nitrosylation of water-soluble iron porphyrins by S-nitroso-N-acetylpenicillamine: Rate constants and EPR characterization.
        J Inorg Biochem 100(11):1722-9. (2006).

205. Flavin-containing monooxygenase activity can be inhibited by nitric oxide-mediated S-nitrosylation. Life Sci 75: 2559-72. (2004).

206. Thermodynamic and Kinetic Studies on the Binding of Nitric Oxide to a New Enzyme Mimic of Cytochrome P450.
          J Am Chem Soc 128: 13611-13624. (2006).

207. S-NO-actin: S-nitrosylation kinetics and the effect on isolated vascular smooth muscle. J Muscle Res Cell Motil 21: 171-81. (2000).

208. Nitric oxide-induced persistent inhibition and nitrosylation of active site cysteine residues of mitochondrial cytochrome-c oxidase in
          lung endothelial cells. Am J Physiol Cell Physiol 288: C840-9. (2005).

209. S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease.
          Proc Natl Acad Sci U S A 104(47):18742-7. (2007).

210. The anti-apoptotic actions of nitric oxide in hepatocytes. Cell Death Differ 6: 952-5. (1999).

211. Hysteretic behavior of methionine adenosyltransferase III. Methionine switches between two conformations of the enzyme with
          different specific activity. J Biol Chem 275: 23476-82. (2000).

212. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem Biophys Res Commun 305: 776-83. (2003).

213. Inhibition of clotting factor XIII activity by nitric oxide. Biochem Biophys Res Commun 249: 275-8. (1998).

214. The skeletal muscle calcium release channel: coupled O2 sensor and NO signaling functions. Cell 102: 499-509. (2000).

215. Nitric oxide and NAD-dependent protein modification. Mol Cell Biochem 138: 201-6. (1994).

216. Creation of a functional S-nitrosylation site in vitro by single point mutation. FEBS Lett 459: 319-22. (1999).

217. Modulation of voltage-gated Ca2+ current in vestibular hair cells by nitric oxide. J Neurophysiol 97(2):1188-95. (2007).

218. Nitrosylcobalamin Promotes Cell Death via S Nitrosylation of Apo2L/TRAIL Receptor DR4. Mol Cell Biol 26: 5588-94. (2006).

219. S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase decreases the enzyme affinity to the erythrocyte membrane.
          Nitric Oxide 2: 17-27. (1998).

220. S-nitrosoglutathione reversibly inhibits GAPDH by S-nitrosylation. Am J Physiol 269: C739-49. (1995).

221. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation.
          Biochem Biophys Res Commun 240: 419-24. (1997).

222. Involvement of glycosylphosphatidylinositol-linked ceruloplasmin in the copper/zinc-nitric oxide-dependent degradation of
          glypican-1 heparan sulfate in rat C6 glioma cells. J Biol Chem 279: 12918-23. (2004).

223. Tyrosine phosphorylation in nitric oxide-mediated signaling events. Methods Enzymol 396: 350-8. (2005).

224. Protein N-homocysteinylation: implications for atherosclerosis. Biomed Pharmacother 55: 443-7. (2001).

225. Nitric oxide-mediated inhibition of caspase-dependent T lymphocyte proliferation. J Leukoc Biol 74: 403-11. (2003).

226. GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions.
          Glia 55(1):65-77. (2006).

227. Acute renal failure: determinants and characteristics of the injury-induced hyperinflammatory response.
          Am J Physiol Renal Physiol 291: F546-56. (2006).

228. Presentation of nitric oxide regulates monocyte survival through effects on caspase-9 and caspase-3 activation.
          J Biol Chem 278: 12894-902. (2003).

229. Reactive nitrogen species derived activation of rat liver microsomal glutathione S-transferase. Life Sci 78(26):2998-3006. (2006).

230. Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism
          against enteroviral cardiomyopathy. Circulation 102: 2276-81. (2000).

231. Regulation of microsomal and cytosolic glutathione S-transferase activities by S-nitrosylation.
          Biochem Pharmacol 63: 1397-404. (2002).

232. Organ specific formation of nitrosyl complexes under intestinal ischemia/reperfusion in rats involves NOS-independent mechanism(s).
          Shock 15: 366-71. (2001).

233. Redox regulation of neuronal survival mediated by electrophilic compounds. Trends Neurosci 30(1):37-45. (2007).

234. Nitric oxide inhibits ornithine decarboxylase by S-nitrosylation. Biochem Biophys Res Commun 262: 355-8. (1999).

235. Nitric oxide-induced inhibition of lung endothelial cell nitric oxide synthase via interaction with allosteric thiols: role of
          thioredoxin in regulation of catalytic activity. Am J Respir Cell Mol Biol 15: 410-9. (1996).

236. Re-evaluation of amino acid sequence and structural consensus rules for cysteine-nitric oxide reactivity.
          Biol Chem 381: 623-7. (2000).

237. Inhibition of Azotobacter vinelandii rhodanese by NO-donors. Biochem Biophys Res Commun 306: 1002-7. (2003).

238. Selective delivery of nitric oxide to a cellular target: a pseudosubstrate-coupled dinitrosyl-iron complex inhibits the enteroviral protease 2A.
        Nitric Oxide 6: 305-12. (2002).

239. Differential role of S-nitrosylation and the NO-cGMP-PKG pathway in cardiac contractility. Nitric Oxide [Epub ahead of print]. (2007).

240. Nitrosylation precedes caspase-3 activation and translocation of apoptosis-inducing factor in neonatal rat cerebral hypoxia-ischaemia.
          J Neurochem 90: 462-71. (2004).

241. Nitrosation and oxidation in the regulation of gene expression. FASEB J 14: 1889-900. (2000).

242. Structural features of proteins responsible for resistance of tryptophan residues to nitrosylation. IUBMB Life 54: 281-92. (2002).

243. Nitric oxide signalling functions in plant-pathogen interactions. Cell Microbiol 6: 795-803. (2004).

244. Elevated endogenous nitric oxide increases Ca(2+) flux via L-type Ca(2+) channels by S-nitrosylation in rat hippocampal neurons
          during severe hypoxia and in vitro ischemia. Free Radic Biol Med 42: 52-63. (2007).

245. Immunohistochemical localization of protein 3-nitrotyrosine and S-nitrosocysteine in a murine model of inhaled nitric oxide therapy.
          Pediatr Res 47: 798-805. (2000).

246. Performance of diamino fluorophores for the localization of sources and targets of nitric oxide. Free Radic Biol Med 38: 356-68. (2005).

247. Nitric oxide inhibits an interaction between JNK1 and c-Jun through nitrosylation. Biochem Biophys Res Commun 351(1):281-6. (2006).

248. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione.
        Proc Natl Acad Sci U S A 95: 7631-6. (1998).

249. Peroxynitrite modification of protein thiols: oxidation, nitrosylation, and S-glutathiolation of functionally important cysteine residue(s) in the
        sarcoplasmic reticulum Ca-ATPase. Biochemistry 38: 12408-15. (1999).

250. Nitric Oxide Regulates Cell Sensitivity to Cisplatin-Induced Apoptosis through S-Nitrosylation and Inhibition of Bcl-2 Ubiquitination.
          Cancer Res 66: 6353-60. (2006).

251. Can Irradiated Tumors Take NO for an Answer? Mol Cell 26: 157-8. (2007).

252. Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO. Proc Natl Acad Sci U S A 98: 11158-62. (2001).

253. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding.
          J Biol Chem 268: 27180-5. (1993).

254. S-Nitrosylation of Human variant albumin Liprizzi (R410C) confers potent Antibacterial and Cytoprotective properties.
          J Pharmacol Exp Ther 320(3):969-77 (2007).

255. Routes to S-nitroso-hemoglobin formation with heme redox and preferential reactivity in the beta subunits.
          Proc Natl Acad Sci U S A 100: 461-6. (2003).

256. Nitric oxide-mediated heme oxidation and selective beta-globin nitrosation of hemoglobin from normal and sickle erythrocytes.
          Biochem Biophys Res Commun 275: 962-7. (2000).

257. Nitric oxide controls src kinase activity through a sulfhydryl group modification-mediated Tyr-527-independent and Tyr-416-linked mechanism.
          J Biol Chem 274: 25821-6. (1999).

258. Signaling through NO and cGMP-dependent protein kinases. Ann Med 35: 21-7. (2003).

259. Hypoxia accelerates nitric oxide-dependent inhibition of mitochondrial complex I in activated macrophages.
          Am J Physiol Regul Integr Comp Physiol 288: R394-400. (2005).

260. Inhibitory effect of polyphenol cyanidin on TNF-alpha-induced apoptosis through multiple signaling pathways in endothelial cells.
          Atherosclerosis 193(2):299-308. (2007).

261. Nitric oxide protects human extravillous trophoblast cells from apoptosis by a cyclic GMP-dependent mechanism and independently
          of caspase 3 nitrosylation. Exp Cell Res 287: 314-24. (2003).

262. A ruthenium (III) polyaminocarboxylate complex, a novel nitric oxide scavenger, enhances graft survival and decreases
          nitrosylated heme protein in models of acute and delayed cardiac transplant rejection. J Cardiovasc Pharmacol 39: 441-8. (2002).

263. Nitric-oxide-directed synaptic remodeling in the adult mammal CNS. J Neurosci 25: 1448-58. (2005).

264. O2-mediated oxidation of hemopexin-heme(II)-NO. Biochem Biophys Res Commun 345: 704-12. (2006).

265. Regulation of endothelial cell apoptosis in atherothrombosis. Curr Opin Lipidol 13: 531-6. (2002).

266. Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein kinase by means of S-nitrosylation.
          Proc Natl Acad Sci U S A 97: 14382-7. (2000).

267. Zn(II)-free dimethylargininase-1 (DDAH-1) is inhibited upon specific Cys-S-nitrosylation. J Biol Chem 278: 3410-6. (2003).

268. Nitric oxide down-regulates MKP-3 mRNA levels: involvement in endothelial cell protection from apoptosis.
          J Biol Chem 275: 25502-7. (2000).

269. Nitric oxide regulation of protein trafficking in the cardiovascular system. Cardiovasc Res 75(2):240-6. (2007).

270. A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteins.
          Mol Pharmacol 69: 501-8. (2006).

271. Calorimetric and structural studies of the nitric oxide carrier S-nitrosoglutathione bound to human glutathione transferase P1-1.
          Protein Sci 15(5):1093-105. (2006).

272. Reversible inactivation of calpain isoforms by nitric oxide. Biochem Biophys Res Commun 207: 1009-14. (1995).

273. Nitric oxide-dependent negative feedback of PARP-1 transaction of the inos gene. J Biol Chem 281(14):9101-9. (2006).

274. Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic
          signaling through S-nitrosylation of caspase-8. Hepatology 32: 770-8. (2000).

275. Life history of eNOS: Partners and pathways. Cardiovasc Res 75(2):247-60. (2007).

276. Nitric oxide synthase inhibition by dimaprit and dimaprit analogues. Br J Pharmacol 127: 331-4. (1999).

277. Nitric oxide mediated modulation of norepinephrine transport: identification of a potential target for S-nitrosylation.
          Br J Pharmacol 130: 1060-4. (2000).

278. cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: potential role for nitrosylation.
          Am J Physiol Heart Circ Physiol 279: H1982-8. (2000).

279. S-nitrosogluthathione reductase activity of amphioxus ADH3: insights into the nitric oxide metabolism.
          Int J Biol Sci 2: 117-24. (2006).

280. A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine.
          J Neurochem 103(3):1219-27. (2007).

281. Nitric oxide inhibits cruzipain, the major papain-like cysteine proteinase from Trypanosoma cruzi.
          Biochem Biophys Res Commun 270: 437-41. (2000).

282. Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. Cell 115: 139-50. (2003).

283. S-nitrosothiol formation. Methods Enzymol 396: 95-105. (2005).

284. Inactivation of brain tryptophan hydroxylase by nitric oxide. J Neurochem 67: 1072-7. (1996).

285. Nitric oxide and oxidative stress in cardiovascular aging. Sci Aging Knowledge Environ 2005: re4. (2005).

286. Inflammatory Mediators Leading to Protein Misfolding and Uncompetitive/Fast Off-Rate Drug Therapy for
          Neurodegenerative Disorders. Int Rev Neurobiol 82: 1-27. (2007).

287. Mechanisms of the protective action of diethyldithiocarbamate-iron complex on acute cardiac allograft rejection.
          Am J Physiol Heart Circ Physiol 284: H1542-51. (2003).

288. An application of electron paramagnetic resonance to evaluate nitric oxide and its quenchers.
          J Am Soc Nephrol 7: 961-5. (1996).

289. Role of nitric oxide in subventricular zone neurogenesis. Brain Res Brain Res Rev 49: 355-66. (2005).

290. Nitric oxide decreases the sensitivity of pulmonary endothelial cells to LPS-induced apoptosis in a zinc-dependent fashion.
          Mol Cell Biochem 234: 211-7. (0).

291. Nitric oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type
          yeast transcription activator LAC9. Biophys Res Commun 200: 1105-10. (1994).

292. Influence of an Extremely Negatively Charged Porphyrin on the Reversible Binding Kinetics of NO to Fe(III) and the
          Subsequent Reductive Nitrosylation. Chem 46(8):3336-52. (2007).

293. Pro- and anti-apoptotic role of nitric oxide, NO. C R Acad Sci III 324: 413-24. (2001).

294. The role of nitric oxide in apoptosis. Semin Perinatol 24: 46-50. (2000).

295. Plasma s-nitrosothiol status in neonatal calves: ontogenetic associations with tissue-specific s-nitrosylation and nitric oxide synthase.
          Exp Biol Med (Maywood) 232: 309-22. (2007).

296. Oxidation and nitrosylation of oxyhemoglobin by S-nitrosoglutathione via nitroxyl anion.
          Free Radic Biol Med 35: 1515-26. (2003).

297. Nitrosylation of blood hemoglobin and renal nonheme proteins in autoimmune MRL-lpr/lpr mice.
          Free Radic Biol Med 24: 191-6. (1998).

298. Nitric oxide inhibits expression of cytochrome B in endotoxin-stimulated murine macrophages.
          Biochem Biophys Res Commun 289: 993-7. (2001).

299. 2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide potentiates nitrosation of a heterocyclic amine
          carcinogen by nitric oxide. Life Sci 80(7):644-9. (2007).

300. Red blood cells generate nitric oxide from directly acting, nitrogenous vasodilators. Toxicol Appl Pharmacol 91: 429-38. (1987).

301. S-nitrosylation signaling in cell biology. Mol Interv 3: 253-63. (2003).

302. L-arginine administration recovers sarcoplasmic reticulum function in ischemic reperfused hearts by preventing calpain activation.
          Cardiovasc Res 69: 152-63. (2006).

303. Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system.
          Proc Natl Acad Sci U S A 101: 7094-9. (2004).

304. Identification of S-nitrosylated proteins after chronic exposure of colon epithelial cells to deoxycholate.
          Proteomics 6(5):1654-62. (2006).

305. The heme-regulated eukaryotic initiation factor 2alpha kinase. A potential regulatory target for control of protein synthesis by diffusible gases.
          J Biol Chem 276: 75-83. (2001).

306. Exercise training in chronic heart failure: correlation between reduced local inflammation and improved oxidative capacity in the skeletal muscle.
          Eur J Cardiovasc Prev Rehabil 12: 393-400. (2005).

307. Preconditioning regulation of bcl-2 and p66shc by human NOS1 enhances tolerance to oxidative stress. FASEB J 14: 2144-6. (2000).

308. Focusing of nitric oxide mediated nitrosation and oxidative nitrosylation as a consequence of reaction with superoxide.
          Proc Natl Acad Sci U S A 99: 11127-32. (2002).

309. Nitric oxide donor SIN-1 inhibits insulin release. Am J Physiol 271: C1098-102. (1996).

310. Variable efficacy of N6-(1-iminoethyl)-L-lysine in acute cardiac transplant rejection.
          Am J Physiol Heart Circ Physiol 286: H525-34. (2004).

311. Specific interaction of methionine adenosyltransferase with free radicals. Biofactors 8: 27-32. (1998).

312. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms.
          Oncogene 22: 5734-54. (2003).

313. Expression of cyclooxygenase-2, alpha 1-acid-glycoprotein and inducible nitric oxide synthase in the developing lesions of murine leprosy.
        Int J Exp Pathol 87: 485-94. (2006).

314. Metallothionein-III prevents glutamate and nitric oxide neurotoxicity in primary cultures of cerebellar neurons.
          J Neurochem 75: 266-73. (2000).

315. Inhibition of nitric oxide synthase and farnesyltransferase change the activities of several transcription factors.
          J Mol Neurosci 31: 281-287. (2007).

316. The human pituitary nitroproteome: detection of nitrotyrosyl-proteins with two-dimensional Western blotting, and amino
          acid sequence determination with mass spectrometry. Biochem Biophys Res Commun 325: 1180-6. (2004).

317. NO stimulation of ATP-sensitive potassium channels: Involvement of Ras/mitogen-activated protein kinase pathway and
          contribution to neuroprotection. Proc Natl Acad Sci U S A 101: 7799-804. (2004).

318. Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins. J Biol Chem [Epub ahead of print]. (2007).

319. Nitric oxide (NO) disrupts specific DNA binding of the transcription factor c-Myb in vitro. FEBS Lett 425: 52-6. (1998).

320. Neuroprotection by pharmacologic blockade of the GAPDH death cascade. Proc Natl Acad Sci U S A 103(10):3887-9. (2006).

321. Nitric oxide-related species-induced protein oxidation: reversible, irreversible, and protective effects on enzyme function of papain.
          Free Radic Biol Med 38: 1102-11. (2005).

322. Biphasic effect of IL-1beta on the activity of argininosuccinate synthetase in Caco-2 cells. Involvement of nitric oxide production.
          Biochimie 88(6):607-12. (2006).

323. Nitric oxide inhibits cornified envelope formation in human keratinocytes by inactivating transglutaminases and activating protein 1.
         J Invest Dermatol 115: 731-9. (2000).

324. Protection from nitrosative stress by yeast flavohemoglobin. Proc Natl Acad Sci U S A 97: 4672-6. (2000).

325. S-nitrosylated and pegylated hemoglobin, a newly developed artificial oxygen carrier, exerts cardioprotection against ischemic hearts.
         J Mol Cell Cardiol 42(5):924-30. (2007).

326. Inhibition of papain by S-nitrosothiols. Formation of mixed disulfides. J Biol Chem 275: 20467-73. (2000).

327. Molecular bases for the anti-parasitic effect of NO (Review). Int J Mol Med 9: 131-4. (2002).

328. Inhibition of cathepsin K by nitric oxide donors: evidence for the formation of mixed disulfides and a sulfenic acid.
          Biochemistry 38: 13574-83. (1999).

329. Interaction of Nitric Oxide with Tetrathiolato Iron(II) Complexes: Relevance to the Reaction Pathways of Iron Nitrosyls in
          Sulfur-Rich Biological Coordination Environments. J Am Chem Soc 128: 3528-9. (2006).

330. Effects of redox-related congeners of NO on apoptosis and caspase-3 activity. Nitric Oxide 1: 282-93. (1997).

331. Inhibition of the catalytic activity of alcohol dehydrogenase by nitric oxide is associated with S nitrosylation and the release of zinc.
          Biochemistry 35: 16186-94. (1996).

332. Regulation of programmed cell death in neuronal cells by nitric oxide. In Vivo 18: 367-76. (0).

333. EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft.
          J Biol Chem 267: 10994-8. (1992).

334. Inactivation of annexin II tetramer by S-nitrosoglutathione. Eur J Biochem 269: 4277-86. (2002).

335. Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cycloxygenase-2.
        Am J Physiol Heart Circ Physiol 290(5):H1960-8. (2006).

336. Does nitric oxide modulate cardiac ryanodine receptor function? Implications for excitation contraction coupling.
          Cardiovasc Res [Epub ahead of print]. (2007).

337. NO: an inhibitor of cell death. Cell Death Differ 6: 937-42. (1999).

338. Physiology of nitric oxide in skeletal muscle. Physiol Rev 81: 209-237. (2001).

339. Reactivity studies of the Fe(III) and Fe(II)NO forms of human neuroglobin reveal a potential role against oxidative stress.
          J Biol Chem 279: 22841-7. (2004).

340. Effect of nitric oxide on albumin-palmitate binding. Biochem Pharmacol 49: 91-6. (1995).

341. Nitric oxide-mediated Ca++-influx in neuronal nuclei and cortical synaptosomes of normoxic and hypoxic newborn piglets.
          Neurosci Lett 318: 93-7. (2002).

342. Regulation of protein tyrosine phosphatase 1B in intact cells by S-nitrosothiols. Arch Biochem Biophys 410: 269-79. (2003).

343. A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. J Biol Chem 272: 4323-6. (1997).

344. Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. J Biochem Mol Biol 35: 116-26. (2002).

345. Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J Biol Chem 270: 7017-20. (1995).

346. Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity.
          Proc Natl Acad Sci U S A 103(40):14919-24. (2006).

347. Effect of staurosporine-induced apoptosis on endothelial nitric oxide synthase in transfected COS-7 cells and primary endothelial cells.
          Cell Death Differ 13(4):597-606. (2006).

348. Translational accuracy of aminoacyl-tRNA synthetases: implications for atherosclerosis. J Nutr 131: 2983S-7S. (2001).

349. Role of nitric oxide in cellular iron metabolism. Biometals 16: 125-35. (2003).

350. The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE 2001: PL1. (2001).

351. Nitric oxide evolution and perception. J Exp Bot [Epub ahead of print]. (2007).

352. Role of heme iron coordination and protein structure in the dynamics and geminate rebinding of nitric oxide to the His93Gly myoglobin mutant :
        Implications for no-sensors. J Biol Chem 281(15):10389-98. (2006).

353. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines.
          Gastroenterology 118: 404-21. (2000).

354. Nitric oxide and S-nitrosylation: excitotoxic and cell signaling mechanism. Biol Cell 95: 3-8. (0).

355. NO+, NO, and NO- donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and
          acceleration of disulfide formation. Arch Biochem Biophys 318: 279-85. (1995).

356. Reactive oxygen and nitrogen species in inflammatory process. Pol Merkur Lekarski 23: 131-6. (2007).

357. Mechanisms of ferriheme reduction by nitric oxide: nitrite and general base catalysis. Inorg Chem 43: 5393-402. (2004).

358. Mechanisms of hepatoprotection by nitric oxide. Ann N Y Acad Sci 962: 415-22. (2002).

359. Effects of interferon-gamma and lipopolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation
          of iron regulatory protein 2. J Biol Chem 275: 6220-6. (2000).

360. Modulatory effect of NO on sodium currents in a neuroblastoma cell line: Aspects of cell specificity. Neurosci Res 58(4):361-70. (2007).

361. Mutation at Glu23 eliminates the neuron growth inhibitory activity of human metallothionein-3.
          Biochem Biophys Res Commun 349(2):674-82. (2006).

362. Pulmonary vasoconstriction by serotonin is inhibited by S-nitrosoglutathione. Am J Physiol Lung Cell Mol Physiol 282: L1057-65. (2002).

363. Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochim Biophys Acta 1658: 44-9. (2004).

364. Cyclic GMP-dependent protein kinase regulates the expression of thioredoxin and thioredoxin peroxidase-1 during hormesis in response to
        oxidative stress-induced apoptosis. J Biol Chem 278: 885-90. (2003).

365. Protein thiols and glutathione influence the nitric oxide-dependent regulation of the red blood cell metabolism. Nitric Oxide 6: 186-99. (2002).

366. Oxidative modification of ion channel activity of ryanodine receptor. Antioxid Redox Signal 2: 35-40. (2000).

367. AMPAR exocytosis through NO modulation of PICK1. Neuropharmacology 53(1):92-100.. (2007).

368. Thioredoxin restores nitric oxide-induced inhibition of protein kinase C activity in lung endothelial cells. Mol Cell Biochem 254: 47-54. (2003).

369. Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia. Leukemia 14: 1685-94. (2000).

370. Activation of c-Ha-Ras by nitric oxide modulates survival responsiveness in neuronal PC12 cells. J Biol Chem 274: 37315-20. (1999).

371. Nitric oxide-mediated modulation of iron regulatory proteins: implication for cellular iron homeostasis. Blood Cells Mol Dis 29: 400-10. (0).

372. Inhibition of glucocorticoid receptor binding by nitric oxide. Mol Pharmacol 55: 317-23. (1999).

373. Nitric oxide signalling by selective beta(2)-adrenoceptor stimulation prevents ACh-induced inhibition of beta(2)-stimulated Ca(2+)
          current in cat atrial myocytes. J Physiol 542: 711-23. (2002).

374. Nitrosylated bovine serum albumin derivatives as pharmacologically active nitric oxide congeners. J Pharmacol Exp Ther 283: 947-54. (1997).

375. Nitrosylation of rabbit ferrous heme-hemopexin. J Biol Inorg Chem 9: 800-6. (2004).

376. Nitric oxide as a regulator of gene expression: studies with the transcription factor proteins cJun and p50. Biofactors 15: 113-5. (2001).

377. Nitric oxide downregulates caveolin-3 levels through the interaction with myogenin, its transcription factor. J Biol Chem 282(32):23044-54. (2007).

378. Nitric oxide directly activates GABA(A) receptor function through a cGMP/protein kinase-independent pathway in frog pituitary melanotrophs.
          J Neuroendocrinol 13: 695-705. (2001).

379. Protein thiol modification and apoptotic cell death as cGMP-independent nitric oxide (NO) signaling pathways.
          Rev Physiol Biochem Pharmacol 127: 1-30. (1996).

380. Nitric oxide and TGF-beta1 inhibit HNF-4alpha function in HEPG2 cells. Biochem Biophys Res Commun 321: 688-94. (2004).

381. Parkin and defective ubiquitination in Parkinson's disease. J Neural Transm Suppl 0: 209-13. (2006).

382. Reversible and irreversible hemichrome generation by the oxygenation of nitrosylmyoglobin. Biochemistry 38: 4750-6. (1999).

383. Nitric oxide blocks fast, slow, and persistent Na+ channels in C-type DRG neurons by S-nitrosylation. J Neurophysiol 87: 761-75. (2002).

384. Regulation of serine racemase activity by D-serine and nitric oxide in human glioblastoma cells. Neurosci Lett 392: 75-8. (2006).

385. Copper-dependent autocleavage of glypican-1 heparan sulfate by nitric oxide derived from intrinsic nitrosothiols.
          J Biol Chem 277: 33353-60. (2002).

386. Attenuation of NMDA receptor activity and neurotoxicity by nitroxyl anion, NO-. Neuron 24: 461-9. (1999).

387. Nitrosyl hemoglobin production during reperfusion after focal cerebral ischemia in rats. Neurosci Lett 177: 165-7. (1994).

388. Free radicals alter maximal diaphragmatic mitochondrial oxygen consumption in endotoxin-induced sepsis.
          Free Radic Biol Med 30: 129-38. (2001).

389. Inactivation of hepatic enzymes by inhalant nitrite-in vivo and in vitro studies. AAPS J 9: E298-305. (2007).

390. Critical role of sulfenic acid formation of thiols in the inactivation of glyceraldehyde-3-phosphate dehydrogenase by nitric oxide.
          Biochem Pharmacol 58: 133-43. (1999).

391. S-nitrosothiols modulate G protein-coupled receptor signaling in a reversible and highly receptor-specific manner. BMC Cell Biol 6: 21. (2005).

392. Electrochemical assay for determining nitrosyl derivatives of human hemoglobin: nitrosylhemoglobin and S-nitrosylhemoglobin.
          Anal Biochem 330: 306-10. (2004).

393. Nitrosative injury and antioxidant therapy in the management of diabetic neuropathy. J Investig Med 52: 33-44. (2004).

394. Immunohistochemical detection of S-nitrosylated proteins. Methods Mol Biol 279: 167-72. (2004).

395. Nitric oxide inhibits apoptosis downstream of cytochrome C release by nitrosylating caspase 9. Cancer Res 62: 1648-53. (2002).

396. Stimulation by nitric oxide of an NAD linkage to glyceraldehyde-3-phosphate dehydrogenase.
          Proc Natl Acad Sci U S A 90: 6238-41. (1993).

397. Direct interaction between the reductase domain of endothelial nitric oxide synthase and the ryanodine receptor.
          FEBS Lett 579: 3159-63. (2005).

398. Catalysis of S-nitrosothiols formation by serum albumin: the mechanism and implication in vascular control.
          Proc Natl Acad Sci U S A 99: 5913-8. (2002).

399. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide.
          Circ Res 89: 709-15. (2001).

400. Nitric oxide modulates tumor cell death induced by photodynamic therapy through a cGMP-dependent mechanism.
          Photochem Photobiol 76: 423-30. (2002).

401. A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription.
        J Mol Cell Cardiol 39: 595-603. (2005).

402. Nitric oxide inhibits calpain-mediated proteolysis of talin in skeletal muscle cells. Am J Physiol Cell Physiol 279: C806-12. (2000).

403. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease
          protein (CPP)-32-like proteases.  J Exp Med 185: 601-7. (1997).

404. Nitric oxide and superoxide, a deadly cocktail. Ann N Y Acad Sci 962: 207-11. (2002).

405. Nitric oxide activates or inhibits skeletal muscle ryanodine receptors depending on its concentration, membrane potential and ligand binding.
          J Membr Biol 173: 227-36. (2000).

406. Maintenance of nitric oxide and redox homeostasis by the Salmonella flavohemoglobin Hmp. J Biol Chem 281(38):28039-47. (2006).

407. Adenylyl cyclase, a coincidence detector for nitric oxide. J Biol Chem 274: 18887-92. (1999).

408. Nitric oxide inhibits falcipain, the Plasmodium falciparum trophozoite cysteine protease. Biochem Biophys Res Commun 267: 190-3. (2000).

409. Activation of the Escherichia coli SoxRS-regulon by nitric oxide and its physiological donors. Biochemistry (Mosc) 66: 984-8. (2001).

410. Vascular regulation by the L-arginine metabolites, nitric oxide and agmatine. Pharmacol Res 49: 397-414. (2004).

411. Beneficial Effect of alpha-Tocopheryl Succinate in Rat Cardiac Transplants. J Heart Lung Transplant 25: 707-715. (2006).

412. Treatment with {alpha}-phenyl-N-tert-butylnitrone, a free radical-trapping agent, abrogates inflammatory cytokine gene expression during
        alloimmune activation in rat cardiac allografts. J Pharmacol Exp Ther 312: 774-9. (2005).

413. S-nitrosylated human alpha(1)-protease inhibitor. Biochim Biophys Acta 1477: 90-7. (2000).

414. Mechanism of covalent modification of glyceraldehyde-3-phosphate dehydrogenase at its active site thiol by nitric oxide, peroxynitrite
          and related nitrosating agents. FEBS Lett 348: 223-7. (1994).

415. Enhanced oxidative stress in iNOS-deficient mice after traumatic brain injury: support for a neuroprotective role of iNOS.
          J Cereb Blood Flow Metab 25: 673-84. (2005).

416. Nitric oxide, a biological double-faced janus--is this good or bad? Histol Histopathol 21: 445-58. (2006).

417. Regulation of caspases by nitric oxide. Ann N Y Acad Sci 962: 42-52. (2002).

418. A novel signaling pathway of nitric oxide on transcriptional regulation of mouse kappa opioid receptor gene. J Neurosci 22: 7941-7. (2002).

419. Inhibition of creatine kinase by S-nitrosoglutathione. FEBS Lett 392: 274-6. (1996).

420. Protein tyrosine nitration is triggered by nerve growth factor during neuronal differentiation of PC12 cells. Exp Cell Res 288: 9-20. (2003).

421. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience 69: 699-703. (1995).

422. Ratio of S-nitrosohomocyst(e)ine to homocyst(e)ine or other thiols determines neurotoxicity in rat cerebrocortical cultures.
          Neurosci Lett 265: 103-6. (1999).

423. Role of protein kinase C in cerebral vasospasm: past and future. Neurol Res 22: 369-78. (2000).

424. Adverse effects of the classical antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress.
          Am J Physiol Cell Physiol [Epub ahead of print]. (2007).

425. Hyperhomocysteinemia and atherosclerosis. Sheng Li Xue Bao 57: 103-14. (2005).

426. Protein thiol modification of glyceraldehyde-3-phosphate dehydrogenase as a target for nitric oxide signaling.
          Genet Eng (N Y) 17: 149-64. (1995).

427. Heme proteins and nitric oxide (NO): the neglected, eloquent chemistry in NO redox signaling and regulation.
          Antioxid Redox Signal 5: 307-17. (2003).

428. An S-nitrosylated hemoglobin derivative protects the rat hippocampus from ischemia-induced long-term potentiation impairment with a time window.
        J Pharmacol Sci 96: 188-98. (2004).

429. Inhibition of calpain is a component of nitric oxide-induced down-regulation of human mast cell adhesion.
          J Immunol 170: 287-93. (2003).

430. Redox modulation of the NMDA receptor. Cell Mol Life Sci 57: 1535-41. (2000).

431. Site-specific detection of S-nitrosylated PKB alpha/Akt1 from rat soleus muscle using CapLC-Q-TOF(micro) mass spectrometry.
          J Mass Spectrom 40: 1140-8. (2005).

432. Determination of S-nitrosohemoglobin using a solid-state amperometric sensor. Nitric Oxide 4: 546-9. (2000).

433. An antiviral mechanism of nitric oxide: inhibition of a viral protease. Immunity 10: 21-8. (1999).

434. Antioxidant treatment inhibits activation of myocardial nuclear factor kappa B and inhibits nitrosylation of myocardial heme protein
          in cardiac transplant rejection. Antioxid Redox Signal 3: 81-8. (2001).

435. Glutathione redox cycle regulates nitric oxide-mediated glyceraldehyde-3-phosphate dehydrogenase inhibition.
          Am J Physiol 272: C99-108. (1997).

436. Crystal structures of ferrous horse heart myoglobin complexed with nitric oxide and nitrosoethane.
          Proteins 53: 182-92. (2003).

437. Inhibition and ADP-ribose pyrophosphatase-I by nitric-oxide-generating systems: a mechanism linking nitric oxide to processes
          dependent on free ADP-ribose. Biochem Biophys Res Commun 213: 1075-81. (1995).

438. Neuroprotective versus neurodestructive effects of NO-related species. Biofactors 8: 33-40. (1998).

439. Tonal nitric oxide and health: anti-bacterial and -viral actions and implications for HIV. Med Sci Monit 8: RA27-31. (2002).

440. Antioxidant mechanisms of nitric oxide against iron-catalyzed oxidative stress in cells. Antioxid Redox Signal 3: 189-202. (2001).

441. Nitric oxide: NO apoptosis or turning it ON? Cell Death Differ 10: 864-9. (2003).

442. Inhibition of apoptosis signal-regulating kinase 1 by nitric oxide through a thiol redox mechanism. J Biol Chem 279: 7584-90. (2004).

443. Nitric oxide: biologic effects on muscle and role in muscle diseases. Neuromuscul Disord 11: 517-24. (2001).

444. Nitric oxide loading of the salivary nitric-oxide-carrying hemoproteins (nitrophorins) in the blood-sucking bug Rhodnius prolixus.
          J Exp Biol 198: 1093-8. (1995).

445. Nitric oxide and differential effects of ATP on mitochondrial permeability transition. Nitric Oxide 6: 45-60. (2002).

446. Identification of hyperreactive cysteines within ryanodine receptor type 1 by mass spectrometry.
          J Biol Chem 279: 34514-20. (2004).

447. The reaction between nitrite and deoxyhemoglobin. Reassessment of reaction kinetics and stoichiometry.
          J Biol Chem 280: 31126-31. (2005).

448. Differential expression of pulmonary nitric oxide synthase isoforms after intestinal ischemia-reperfusion.
          Hepatogastroenterology 50: 31-6. (0).

449. Nitrosylation of manganese(II) tetrakis(N-ethylpyridinium-2-yl)porphyrin: a simple and sensitive spectrophotometric assay for nitric oxide.
          Nitric Oxide 4: 526-33. (2000).

450. Altered response to partial bladder outlet obstruction in mice lacking inducible nitric oxide synthase.
          J Urol 163: 1981-7. (2000).

451. Structure of the photoreactive iron center of the nitrile hydratase from Rhodococcus sp. N-771. Evidence of a novel post-translational modification in
        the cysteine ligand. J Biol Chem 272: 29454-9. (1997).

452. Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS.
        Microvasc Res 71: 20-31. (2006).

453. Protein linguistics - a grammar for modular protein assembly? Nat Rev Mol Cell Biol 7: 68-73. (2006).

454. Inactivation of NADP(+)-dependent isocitrate dehydrogenase by nitric oxide. Free Radic Biol Med 33: 927-37. (2002).

455. Nitric oxide inhibits lipopolysaccharide-induced apoptosis in pulmonary artery endothelial cells.
          Am J Physiol 275: L717-28. (1998).

456. Roles of protein C, protein S, and antithrombin III in acute leukemia. Am J Hematol 81: 171-174. (2006).

457. CELL BIOLOGY: The Prion Protein Has a Good Side? You Bet. Science 311: 1091. (2006).

458. Evidence for nitric oxide mediated effects on islet hormone secretory phospholipase C signal transduction mechanisms.
          Biosci Rep 18: 199-213. (1998).

459. Regulation of transforming growth factor beta1 by nitric oxide. Cancer Res 59: 2142-9. (1999).

460. Nitric oxide deficit in chronic intermittent hypoxia impairs large conductance calcium-activated potassium channel activity in
          rat hippocampal neurons.
        Free Radic Biol Med [Epub ahead of print]. (2007).

461. Antithrombotic effects of peroxynitrite: inhibition and reversal of aggregation in human platelets.
          Prostaglandins 50: 169-78. (1995).

462. New Insights into Nitric Oxide Signaling in Plants. Annu Rev Plant Biol [Epub ahead of print]. (2007).

463. FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues.
          Biochem Biophys Res Commun 342(2):472-81. (2006).

464. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis.
          Proc Natl Acad Sci U S A 92: 12041-5. (1995).

465. Nitric oxide: an inhibitor of NF-kappaB/Rel system in glial cells. Brain Res Bull 52: 155-61. (2000).

466. Transcriptional regulatory functions of heterogeneous nuclear ribonucleoprotein-U and -A/B in endotoxin-mediated
          macrophage expression of osteopontin. J Immunol 175: 523-30. (2005).

467. Modulation of AP-1 activity by nitric oxide (NO) in vitro: NO-mediated modulation of AP-1. FEBS Lett 351: 123-7. (1994).

468. Nitric oxide binding to ferrous native horse heart cytochrome c and to its carboxymethylated derivative: a spectroscopic and
          thermodynamic study. J Inorg Biochem 53: 273-80. (1994).

469. Mutual regulation between serine and nitric oxide metabolism in human glioblastoma cells. Neurosci Lett 394: 163-7. (2006).

470. The action of dextrorphan and sigma ligands on the spontaneous secretion of interleukins by jurkat cell line.
          Georgian Med News 0: 74-6. (2005).

471. Agonist-induced ADP-ribosylation of a cytosolic protein in human platelets. Proc Natl Acad Sci U S A 87: 3304-8. (1990).

472. Gating prokaryotic mechanosensitive channels. Nat Rev Mol Cell Biol 7: 109-19. (2006).

473. Reduction of ferrylmyoglobin and ferrylhemoglobin by nitric oxide: a protective mechanism against ferryl
         hemoprotein-induced oxidations. Biochemistry 34: 6689-99. (1995).

474. p130cas is a cellular target protein for tyrosine nitration induced by peroxynitrite. Neurosci Res 33: 325-8. (1999).

475. Spin trapping of glutathiyl and protein radicals produced from nitric oxide-derived oxidants. Free Radic Biol Med 36: 1224-32. (2004).

476. Rates of nitric oxide dissociation from hemoglobin. Free Radic Biol Med 39: 145-51. (2005).

477. Caspase-mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide. Mol Med 3: 750-64. (1997).

478. S-nitrosation ameliorates homocysteine-induced neurotoxicity and calcium responses in primary culture of rat cortical neurons.
          Neurosci Lett 265: 99-102. (1999).

479. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds.
          Proc Natl Acad Sci U S A 89: 444-8. (1992).

480. Heart failure, oxidative stress, and ion channel modulation. Congest Heart Fail 8: 148-55. (0).